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ABSTRACT   
Biosurfactants have recently been shown to have properties as potentially new generation of 
antiadhesive and antibiofilm agents. Sophorolipids in particular are a relevant biosurfactant 
molecules known as therapeutic agents. The aim of this study was to evaluate antimicrobial 
properties of sophorolipids in medical-grade silicone discs using strains of clinical relevance. 
Sophorolipids were produced under fed batch conditions, ESI-MS analyses were carried out 
to confirm the congeners present in each formulation. Three different products were obtained 
SLA (acidic congeners), SL18 (lactonic congeners) and SLV (mixture of acidic and lactonic 
congeners). The effect of SLA, SL18 and SLV were tested against Staphylococcus aureus 
ATCC 6538 and Candida albicans IHEM 2894. All three congener mixtures showed a 
disruption effect (> 0.1% w/v) of 70% for S. aureus biofilms and 80% on C. albicans 
biofilms. On pre-coated silicone disks, biofilm formation of S. aureus was reduced by 75% 
using SLA 0.8% w/v. After 1.5h the inhibition of C. albicans attachment was between 45-
56% whilst after 24h incubation the percentage of inhibition for the cell attachment increased 
to a range between 68-70% when using SLA 0.8% w/v. Finally, in co-incubation experiments 
SLA 0.05% w/v significantly reduced the ability of S. aureus and C. albicans to form 
biofilms and to adhere to surfaces by 90-95% at concentrations between 0.025-0.1% w/v. In 
conclusion sophorolipids reduced significantly the cell attachment of both tested strains 
which suggests that these molecules could have a potential role as coating agents on medical 
grade silicone devices for the preventions of bacterial and yeast infections.  
Keywords 
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INTRODUCTION 
Surfactants are amphiphilic molecules that are contained in a significative number of 
products in use daily and therefore are part of all aspects of our daily lives. Their properties 
make them very useful to many industrial and domestic applications, with a global production 
exceeding 13 million tonnes per year (Marchant and Banat, 2012). Approximately half of this 
amount is used in domestic and laundry detergents and as a consequence of their use they 
ultimately end up in the environment (Van Bogaert et al., 2010). Surfactants of biological 
origin, biosurfactants, unlike the chemical counterparts, are often synthesized from renewable 
resources or waste through fermentation processes. Such methods produce compounds with a 
higher biodegradability and lower eco-toxicity (Van Bogaert et al., 2010). Nowadays the 
industrial demand of new surfactants that are both effective and eco-friendly is continuously 
growing. Sophorolipids are obtained from non-pathogenic yeast strains and also stand out for 
their high production yield (Van Bogaert et al., 2010). 
Interest in the use of biosurfactants in general is steadily increasing in healthcare associated 
applications to reduce infections (Krasowska, 2010) particularly, involving their use in 
controlling biofilms formation and/or their disruption. Previous studies have shown that the 
interaction of biosurfactants with different surfaces can affect their hydrophobic properties 
affecting the microorganisms adhesion step of and consequent biofilm formation (Shah et al., 
2007). Sophorolipids showed bactericidal properties when compared to conventional 
antimicrobial agents with bacteriostatic effects (Diaz De Rienzo et al., 2015). Previous 
studies showing the anti-adhesive properties of biosurfactants have used pure cultures of 
microorganisms, however, analysis of a typical biofilm reveals predominantly mixed 
cultures. Additionally, the nutritional composition of biofilms have been shown to affect the 
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adhesion characteristics of single and mixed cultures (Zezzi do Valle Gomes and Nitscke, 
2012). This work aims to target the antimicrobial effect of sophorolipids on microbial strains 
of clinical relevance: Candida albicans and Staphylococcus aureus. C. albicans is the most 
common fungal human pathogen causing diseases ranging from superficial mucocutaneous 
infections to life-threatening candidiasis (Pfaller and Diekema, 2007; Ganguly and Mitchell, 
2011). S. aureus is a pathogen microorganism responsible for an important number of clinical 
infections, including bacteraemia, and device-related infections among others (Tong et al., 
2015). In this study we aim to investigate the effects of sophorolipids on the disruption of 
biofilm formation, and their antimicrobial properties against Candida albicans IHEM 2894 
and Staphylococcus aureus ATCC 6538 using medical grade silicone material. 
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MATERIALS AND METHODS 
Microorganisms and media 
Candida bombicola ATCC 22214 was the microorganism used to produce sophorolipids, it 
was stored in nutrient broth with 20% glycerol at -80C until further use. The culture medium 
for the production of sophorolipids was GYU: glucose/yeast extract/urea (Diaz De Rienzo, et 
al 2015). Rapeseed oil, was used as a second carbon source, fed at regular intervals to induce 
sophorolipid production. Candida albicans IHEM 2894 strain was cultivated in YNBD: 
Yeast Nitrogen Base broth + 50 mM Dextrose and stored at -80C until further use. 
Staphylococcus aureus ATCC 6538, was cultivated in Tryptic Soy Broth + 10 g/L glucose 
and stored at -80C until further use. 
Production of sophorolipids 
Crude SL mixtures were obtained as crude extract from fed batch cultivation of C. bombicola 
ATCC 22214 (Shah et al., 2005), feeding glucose and oleic acid rather than waste frying oil 
at 1.5%, 2% and 4% w/v to induce the production of different congeners. The dry matter 
content was classified as SLA (acidic congeners), SL18 (lactonic congeners) and SLV 
(mixture of both congeners). Sophorolipids were extracted and partially purified by chemical 
extraction (Smyth et al., 2009). For mass analysis, partially purified sophorolipids were 
dissolved in methanol and characterised by electrospray ionisation–mass spectrometry (ESI–
MS) using a Waters LCT mass spectrometer in negative-ion mode. Data was collected via 
direct infusion using a syringe pusher over 0.5/mins in methanol. A desolvation temperature 
of 200ºC was applied together with a Desolvation Gas Flow (L/hr) of 694 and a capillary 
voltage of 3000V. 
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Medical-grade silicone elastomeric disks preparation. 
Medical-grade silicone elastomeric disks (SEDs) of 10 mm in diameter, 1.5mm in thickness 
were used for experiments in 24-well culture tissue plates, each silicone disk was cleaned, 
sterilized and conditioned according to Ceresa et al., 2016 with minor modifications. The 
disks were sonicated for 5 min at 60 kHz using Elma S30H and rinsed two times with 
distillate water. Then, disks were submerged in 20 ml of MeOH, sonicated for 5 min at 60 
kHz, rinsed twice and steam sterilized for 15 min at 121°C.  
Antimicrobial susceptibility of Candida albicans and Staphylococcus aureus biofilm 
towards sophorolipids. 
C. albicans IHEM 2894 biofilm were formed according to Chandra et al., 2008. Fungal cells
were suspended in Phosphate Buffered Saline +10% Fetal Bovine Serum and adjusted up to 
1.10
7 
CFU/ml. The discs were inoculated with 1ml of the suspension, after the adhesion phase
(1.5h), the disks were moved into a new 24-well plate in the presence of 1ml of YNBD +10% 
FBS and incubated for 24h at 37°C at 90rpm to promote the biofilm growth phase.  
S. aureus ATCC 6538 was grown in TSB + 10g/L glucose, and the suspension was adjusted
up to a concentration of 1.10
7
 CFU/ml. Silicone disks were submerged with 1 ml of bacterial
suspension and incubated for 24h at 37°C in static conditions as described before.  
Microbial pre-formed biofilms were then treated with different concentrations of SLA and 
SL18 ranging from 0.05%-0.4%, of SLV ranging from 0.025%-0.2% and incubated for 24h at 
37°C. The antifungal activity of SLA, SLV and SL18 was evaluated according to the method 
described by Ceresa et al. 2016. Disks incubated for 48h C. albicans IHEM 2894 biofilm and 
24h for  S. aureus ATCC 6538 were washed three times with PBS for removal of non-
adherent cells and moved in 1 ml of 0.3% MTT solution supplemented with 0.01% glucose 
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and 1μM menadione. After 30 min of incubation time at 37°C, formazan crystals were 
dissolved with 1ml of DMSO/0.1M glycine buffer (pH 10.2) solution (7:1). From each 
biofilm, 200 µl were transferred to a new 96-well plate and the absorbance was measured at 
570 nm. The assay was carried out in triplicate and repeated three times for all of SLA, SLV 
and SL18 concentrations used for the test (n=9).  
Disruption properties of sophorolipids towards Candida albicans and Staphylococcus 
aureus. 
Co-Incubation 
Silicone disks were submerged in 500 µl of C. albicans IHEM 2894 inoculum (2.10
7
 CFU/ml
in PBS + 20% FBS) and an equal volume of double-concentrated SLA (0.05%), SL18 
(0.05%) and SLV solutions (0.025% and 0.05%) (test groups) or PBS (control group). After 
the adhesion phase, disks were placed in a new plate containing 1 ml of YNBD + 10% FBS + 
0%, 0.025%, 0.05%, 0.1% SLs and incubated for 24h at 37C and 90rpm.  
For S. aureus ATCC 6538, silicone disks were inoculated with an equal volume of a bacterial 
suspension (2.10
7
 CFU/ml in TSB 2X + 2%G) and SLs (0.05%, 0.1%, 0.2%) or PBS and
incubated at 37°C for 24h. 
The biofilm biomass was quantified by the crystal violet (0.2%) essay. Biofilms were washed 
three times with PBS, air-dried and coloured for 10 min and the absorbance at 570nm was 
measured. Assays were carried out in triplicate and the experiments were repeated three times 
(n=9). 
Pre-coating 
Elastomeric disks were dipped in 1 ml of SLs solutions at concentrations ranging from 0.2% 
to 0.8% (test groups) or PBS (control group) and incubated for 24h at 37C and180rpm.  
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In the case of C. albicans, disks were moved into 24-well plates containing 1 ml of 
suspension, standardised to 1.10
7
 CFU/mL in PBS + 10% FBS. After the adhesion phase, the 
disks were transferred into a new plate as described before in the co-incubation section.  
In the case of S. aureus, disks were incubated with 1 ml of the bacterial suspension at the 
concentration of 1.10
7
 CFU/mL at 37°C for 24h.  
The anti-adhesion and anti-biofilm activity of SLs-coated disks were evaluated respectively 
after 1.5h and 24h using the previously described CV staining method. Assays were carried 
out in triplicate and experiments were repeated two times (n=6).  
 
SEM Analysis  
The effect of SLA, SL18 and SLV on cells of Candida albicans IHEM 2894 and 
Staphylococcus aureus ATCC 6538 were evaluated through SEM according to the method 
described by Ceresa et al., 2016. Each disk was washed three times in PBS, fixed in a 2.5% 
glutaraldehyde solution for 24h at 4°C, washed twice in distilled water, dehydrated and dried 
overnight. SEM analyses were conducted in a FEI QUANTA 200 with a variable range 1-30 
KV beam voltage.  
 
Statistical Analysis  
Statistical analysis was carried out by means of the statistical program R (R Development 
Core Team, http//www.R-project.org). ANOVA followed by Tukey’s HSD post-test was 
used to compare the effect of different SLA, SL18 and SLV concentrations against C. 
albicans IHEM 2894 and S. aureus ATCC 6538 biofilm formation and pre-formed biofilm in 




RESULTS AND DISCUSSION 
Fermentation process: Sophorolipids production 
Candida bombicola ATCC 22214 was able to produce sophorolipids under aerobic 
conditions, on GYU medium at 30°C using oleic acid (as a second carbon source) at different 
concentrations after 120h. The production of sophorolipids starts when the yeast cells enter in 
stationary phase once they have been triggered by a high carbon/nitrogen ratio (Davila et al., 
1992). Typically, growth rate is dependent upon the hydrophilic substrate used; in our study, 
glucose is the hydrophilic substrate of choice whilst oleic acid was chosen as the hydrophobic 
substrate for sophorolipid synthesis. 
Different studies have shown that the use of a second lipidic carbon source helps to increase 
the production yield of sophorolipids. Particularly favourable sources include rapeseed oil 
and most vegetable oils that are rich in C16-18 fatty acids; these carbon sources are more 
favourable to renewable production practices, readily incorporated into the sophorolipid 
molecule, and add an additional control over molecular diversity (Saerens et al., 2015; 
Delbeke et al., 2016). During SL biosynthesis, the enzyme CYP52M1 catalyses oxygenation 
of the fatty acids. The enzyme largely determines the length of the fatty acid chain within the 
molecule and has a high specificity towards stearic acid (18 carbons, 0 double bonds, C18:0) 
and oleic acid (C18:1) which are then mirrored in the fatty acid model of the sophorolipid 
molecule. However, the sophorolipids produced by C. bombicola are not typically pure 
compounds but consist of a mixture of molecules with variations in molecular weights, chain 
length, position of hydroxylation and differences in the saturation of the fatty acid chain (Van 
Bogaert et al., 2007). The organism has a preference to produce lactonic congeners of the 
SLs, however they are typically produced as a mixture of different congeners with two major 
points of variation: acetylation in the sophorose moiety, and lactonisation (Costa et al., 2018). 
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The achievement of such congeners is particularly important when considering the potential 
therapeutic applications, since acidic and lactonic SLs have been demonstrated as having 
different physicochemical and biological activities. Lactonic SLs for example show higher 
antimicrobial, virucide, and anti-cancer activity (Shao et al., 2012), whereas acidic SLs show 
higher spermicidal and proinflammatory activity (Shah et al., 2005). The predominance for 
the production of the acidic or lactonized form is mostly dependant on the tendency of the 
metabolic route, which is affected by the fermentation time and hydrophobic substrate used 
(Daniel et al., 1998). In this study, changing the concentration of oleic acid and varying the 
fermentation process in terms of time had an effect on the production of different congeners 
(Fig. 1). 
ESI–MS analysis of each purified product was carried out, Fig. 1A revealed the presence of a 
sophorolipid congener produced by C. bombicola ATCC 22214 when grown in 2% v/v oleic 
acid.  A dominant peak in the ESI–MS showed a pseudomolecular ion of m/z 621-622 (Fig. 
1A), corresponding to a nonacetylated C18:0 SL. This form has previously been reported 
(Kasturi and Prabhune, 2013) and it is one of the acidic congeners; for this study, it has been 
denominated as SLA for all antimicrobial experiments carried out. The presence of the 
different congeners was observed when the concentration of oleic acid was changed to 1.5% 
and 4% v/v. Different peaks were detected (Fig. 1b) corresponding to different acidic and 
lactonic congeners (Table 1) (Fig. 1b). For all the antimicrobial experiments, the product that 
contains a mixture of acidic and lactonic congeners was called SLV. The purified product 
that mainly consisted of the lactonic form of sophorolipids, on the other hand was designated 
as SL18. 
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The effect of acidic SLA, lactonic SL18 and mixed SLV sophorolipids on pre-formed 
biofilms by C. albicans IHEM 2894 and S. aureus ATCC 6538 on medical-grade silicone 
elastomeric disks. 
The ability of SLA, SL18 and SLV to disrupt biofilms formed by either C. albicans or S. 
aureus was tested through the MTT assay. Optical densities at 570nm of each microorganism 
vs individual biosurfactant concentrations are shown in Fig. 2. Both of the strains tested 
showed the ability to form biofilms on medical-grade silicone discs under the conditions 
described here. The combined effect of all biosurfactants used (concentrations above 0.1% 
w/v) on the disruption on the S. aureus biofilms was significant. An average of 70% lower 
metabolic activity was estimated through the MTT assay, using NAD (P) H-dependent 
cellular oxidoreductase enzyme (under the conditions used in this study) as a reflection of the 
number of viable cells present (Berridge et al., 2005) (Fig. 2). However, analysis of the SEM 
images revealed a less significant effect, indicating that the biofilm structure was preserved 
post-treatment (Fig. 3). 
The Gram-positive microorganism S. aureus is able to produce a multi-layered biofilm matrix 
representing subpopulations of bacteria embedded within a glycocalyx (Archer et al., 2011). 
Infections caused by methicillin resistant S. aureus (MRSA) are a serious problem with a 
high occurrence in hospital inpatients and healthcare professionals. Some anti-staphylococcal 
antibiotics are available, although the treatment options for MRSA infections remain limited 
due to the increasing occurrence of antibiotic resistant phenotypes (Samadi et al., 2012). 
Additional environmental factors such as the selective pressures within the distinct matrix 
layers have been shown to further encourage resistance (Xu et al., 2000; Singh et al., 2010) 
highlighting the importance of developing effective biofilm disruptor therapies. The thickness 
of the biofilms formed by these microorganisms are expected to be more than 400µm 
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(Costerton et al., 1995), which could be the main reason why disruption mediated by 
sophorolipids was not evident through SEM, the 3D structure of the biofilm were still visible 
but the cells that formed this structure were metabolically compromised as indicated by the 
MTT assay. Such bactericidal effect of sophorolipids on mixed cultures of B. subtillis and 
Staphylococcus aureus have been reported before (Diaz De Rienzo et al., 2015), which gives 
an added value to these molecules for potential biomedical applications.  
C. albicans usually produces biofilms composed of multiple cell types (i.e., round, budding
yeast-form cells; oval pseudohyphal cells; and elongated, cylindrical hyphal cells) encased in 
an extracellular matrix (Chandra et al., 2001; Dominic et al., 2007). These microorganisms 
are responsible for at least 15% of the total sepsis cases acquired within a clinical setting, 
moreover, their occurrence accounts for the fourth most common determinant of bloodstream 
infections in clinical settings, and the predominant fungal species isolated from medical 
device infections (Wenzel, 1995; Wisplighoff, 2004), therefore highlighting the importance 
of the disruption on medical-grade silicone discs.  
The disruptive effects of SLA, SLV (at all the concentrations tested) and SL18 (at 
concentrations above 0.1% w/v) on C. albicans IHEM 2894 biofilms showed 80% inhibition 
(evaluated as an indirect measure of the metabolic activity) (Fig. 4). This effect was 
confirmed by SEM images, which showed clear biofilm disruption and lower number of cells 
attached (Fig. 5).  To our knowledge, this study is the first reporting sophorolipids as 
antimicrobial disruptors of C. albicans biofilms. The recent emergence of lipopeptide 
biosurfactants as a new generation of agents with anti-adhesive and antimicrobial properties 
with enhanced biocompatibility provide potential commercial applications in the 
pharmaceutical and biomedical fields (Cameotra and Makkar, 2004; Fracchia et al., 2015; 
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Ceresa et al., 2016). This work shows the potential use of lactonic sophorolipids as disruptive 
agents at concentrations as low as 0.05% w/v.  
 
Antimicrobial properties of SLA, SL18 and SLV on C. albicans IHEM 2894 and S. 
aureus ATCC 6538 
The antimicrobial effect of SLA, SL18 and SLV (at different concentrations) on both 
microbial strains were evaluated under co-incubation experimental conditions. All the 
treatments resulted in a significant reduction of the total adherent cells and biofilm biomass 
compared to the controls. SLA (at 0.05% and 0.1% w/v) was the treatment that showed the 
highest impact in preventing the attachment of both S. aureus and C. albicans cells, although 
lactonic SLs have been reported to have better surface tension lowering and antimicrobial 
activity as compared to the acidic form (de Oliveira et al., 2015). Under the conditions of the 
present study, the acidic form displayed superior antimicrobial activity. The findings 
presented here are thought to be mainly due to the hydrophilic properties of the SLs in 
solution enabling the formation of smaller globular micelles, which therefore interact more 
closely with the microbial cells. 
 
The antimicrobial effect of sophorolipids on S. aureus cells have been reported before (Diaz 
De Rienzo et al., 2015) where sophorolipids (a congeners mix) at 5% v/v induced disruption 
on mature maximal biofilms of B. subtilis BBK006 as well as a mixed culture containing B. 
subtilis BBK006 and S. aureus ATCC 9144. In both cases, the cells exhibited an outpouring 
of cytoplasmic contents due to the presence of the intracellular enzyme malate 
dehydrogenase, indicating the interaction of sophorolipids with the cellular membrane 
increasing permeability (Dengle-Pulate et al., 2014). In this study, the concentration used was 
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50 times lower (0.05% w/v) and the inhibition on the biofilm biomass was up to 90% with no 
visible cytoplasmic content.   
To our knowledge, there is no report on the antimicrobial effect of sophorolipids on the 
inhibition on the biofilm biomass of C. albicans when co-incubated with concentrations 
between 0.025-0.1% w/v of sophorolipids concentration. In this study, the experiments were 
carried out at two different times: 1.5h and 24h. In general, the highest reduction in the cell 
attachment (>95%) was achieved after 24h of incubation. Different studies showed the effect 
of different biosurfactants against C. albicans biofilms (Ceresa et al., 2016), where the effect 
of a lipopeptide AC7 BS (0.5-3 mg/ml) was evaluated on C. albicans 40, C. albicans 42 and 
C. albicans IHEM 2894, resulting in a significant reduction of the total adherent cells and
biofilm biomass (with a maximum inhibition of 68% at 2mg/ml). Additionally, the influence 
of lipopeptides from Bacillus amyloliquefaciens strain on polystyrene plates was shown to 
inhibit C. albicans biofilm formation between 46-100% (depending on the concentration and 
on Candida strains) (Rautela et al., 2014). 
Anti-adhesive properties of SL18 on biofilms formed by Candida albicans IHEM 2894 
and Staphylococcus aureus ATCC 6538 
The anti-adhesive properties of SL18 were tested on cells of both S. aureus (after 24h) and C. 
albicans (at 1.5h and after 24h). Concentrations from 0.2-0.8% w/v were tested, and total 
biofilm biomass was quantified (Fig. 6). Pre-coating experiments revealed the biofilm 
formation and adhesion properties of all microorganisms were progressively reduced as a 
function of increased SL concentrations, with SL18 showing the greatest inhibitory effect 
towards cell attachment to the silicone disks. Biosurfactants are able to disrupt phospholipid 
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membranes and affect the cell-to-cell surface interactions by decreasing hydrophobicity and 
interfering with the cell deposition and microbial adhesion processes (Rodrigues et al., 2006). 
Certain structural analogues of SLs have been shown in previous studies to inhibit conidia 
germination in the fungus Glomerella cingulata (Kitamoto and Isoda, 2002). SLs have also 
demonstrated an inhibitory effect on the growth of some Gram-positive bacteria, which 
include Bacillus subtilis, Micrococcus luteus, and Mycobacterium rubrum (Elshikh et al., 
2017), and Streptococcus oralis, as well as Gram-negative bacteria including Escherichia 
coli, Serratia marcescens (de Oliveira et al., 2015), and Neisseria mucosa (Elshikh et al., 
2017) when deposited onto polystyrene surfaces. Antimicrobial activity of lactonic 
sophorolipids (98% lactonic SL mixture composed of C18:1 and C18:0) was previously 
reported (Ashby et al., 2011) for action against Propionibacterium acnes, and demonstrate 
inhibitory action at 2.4 mg/ml on films of pectin- and alginate-based SL composites. 
In this study S. aureus ATCC 6538 cells were incubated for 24h (Fig. 6A), and a 75% 
inhibition on the cell attachment was visible when SL18 (0.8% w/v) was used, in comparison 
to the controls where the silicone discs were not pre-treated using biosurfactants. Previous 
studies have shown pre-treatment of catheters using minocycline and rifampin significantly 
decreases the incidence of central line-associated bloodstream infections caused by S. aureus 
in a medical intensive care unit in a manner that was independent and complimentary to 
precautionary measures for infection control (Ramos et al., 2011). However, this is the first 
time that pre-treatment of medical grade silicone discs with SL18 has shown a high 
percentage of inhibition after 24h incubation.  
In the assays with C. albicans analysis was carried out at 1.5 and 24h incubation (Fig. 6B and 
6C). At 1.5h the C. albicans cells were in the initial phase of adhesion and the yeast cell 
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counts were very low compared with the 24h incubation (as can be seen through the SEM 
images).  After 1.5h the inhibition was in the range of 45-56% whilst after 24h the percentage 
of inhibition on the cell attachment increased (using 0.8% w/v) was in the range of 68-70%. 
These results are in contrast to previous reports (Ceresa et al., 2016), where the medical 
silicone discs treated with 2 mg/ml the biosurfactant AC7 BS were able to significantly 
reduced the cell attachment (C. albicans) at a range of 57.7–62.0 % at 1.5 h and in a range of 
45.9–47.6 % after 24h of incubation. This is a clear indication that the inhibition at different 
stages depends on the disk treatment, referring to the nature of the antimicrobial agent. 
Our results indicate that sophorolipids (in any congener form) are able to reduce the biofilm 
biomass that is able to form 3D mature films on medical grade silicone discs under the 
conditions tested in this study. These results also display strong anti-adhesive properties with 
up to 75% inhibition in the pre-treated group. However, further investigations are needed to 
explore the effects of lower concentrations, as well as studies of cytotoxicity to be able of 
extend the use of sophorolipids as antimicrobial molecules with commercial impact in 
different biotechnology fields.  
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Table 1. Identification of sophorolipid analogs based on m/z peaks in negative mode [M- H
+
] 
SL structural forms  /  [M- H+] 
Nonacetylated SL of C18:0, acidic form 623 
Diacetylated SL of C16:0, lactonic form 661 
Monoacetylated SL of C18:1, acidic form 663 
Diacetylated SL of C18:2, lactonic form 685 





















Figure 1. A. ESI-MS analysis of SLA. Spectrum of partially purified extracts from fermented cells of Candida 
bombicola ATCC 22214. Oleic acid 2% was induced after 48h and 120h. B. ESI-MS analysis of  SLV. 
Spectrum of partially purified extracts from fermented cells of Candida bombicola ATCC 22214. Oleic acid  
4% was induced once after 48h. 
A 
B 
ALC_G #160-1682 RT: 3.97-39.99 AV: 1523 NL: 1.35E7
F: - c ESI Full ms [ 110.00-2000.00]
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Figure 2. Sophorolipids activity against S. aureus 24h pre-fromed biofilm on medical grade silicone disks, 




Figure 3. Scanning electron micrographs of S. aureus 24h pre-formed biofilm after 24h (A), under SL18 0.1% 
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Figure 4. Sophorolipids activity against C. albicans 24h pre-fromed biofilm on medical grade silicone disks, 




Figure 5. Scanning electron micrographs of C. albicans 24h pre-formed biofilm after 24h (A), under SLA 0.1% 
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Figure 7. Activity of sophorolipids on co-incubation experiments. Biofilms formed by (A) S. aureus 24h and 
(B) C. albicans 1.5h and (C) C. albicans 24 evaluated by crystal violet assay. Scanning electron micrographs
showed the control cells (left) and tretaed with SLA 0.1% w/v (right).
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